New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study.

Saved in:
Bibliographic Details
Title: New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study.
Authors: Karpinski MJ; Department of Nuclear Medicine, DKTK and NCT University Hospital Essen, Essen, Germany; Department of Nuclear Medicine, University Hospital Münster and West German Cancer Center, Münster, Germany; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Civan C; Department of Nuclear Medicine, DKTK and NCT University Hospital Essen, Essen, Germany; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Rauscher I; Department of Nuclear Medicine, School of Medicine and Health, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany., Güven O; Department of Nuclear Medicine, School of Medicine and Health, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany., Eiber M; Department of Nuclear Medicine, School of Medicine and Health, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany; Bavaria Cancer Research Centre (BZKF) Munich, Munich, Germany., Hoberück S; Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Miederer M; Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany; Department of Translational Imaging in Oncology, National Center for Tumour Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, University of Technology Dresden (TUD), Dresden, Germany., Bundschuh RA; Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Hölscher T; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany., Calais J; Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Theus L; Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Nguyen AT; Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Scholtissek H; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Lapa C; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Di Giorgio A; Nuclear Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Farolfi A; Nuclear Medicine, IRCCS, Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy., Ufton D; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Drzezga A; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Kunikowska J; Nuclear Medicine Department, Medical University of Warsaw, Warsaw, Poland., Pełka K; Nuclear Medicine Department, Medical University of Warsaw, Warsaw, Poland., Evangelista L; Division of Nuclear Medicine, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Bauman G; Department of Oncology, Western University, London, ON, Canada., Alçın G; Istanbul Training and Research Hospital, Clinic of Nuclear Medicine, Istanbul, Turkey., Beintner-Skawran S; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Rohani MFM; Department of Nuclear Medicine, Hospital Kuala Lumpur, Malaysia; Department of Nuclear Medicine, Institut Kanser Negara, Putrajaya, Malaysia., Miksch J; Department of Nuclear Medicine, University Hospital Ulm, Ulm, Germany; Department of Radiology, University Hospital Ulm, Ulm, Germany., Hüsing A; Institute of Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany., Kesch C; Department of Urology, DKTK and NCT University Hospital Essen, Essen, Germany., Herrmann K; Department of Nuclear Medicine, DKTK and NCT University Hospital Essen, Essen, Germany., Stuschke M; Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Umutlu L; Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany., Gafita A; Johns Hopkins University School of Medicine, The Russell H Morgan Department of Radiology, Baltimore, MD, USA., Hofman MS; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Hope TA; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Goffin K; Nuclear medicine, University Hospitals Leuven, KU Leuven, Leuven, Belgium; Nuclear Medicine & Molecular Imaging, Department of Imaging & Pathology, KU Leuven, Leuven, Belgium., Kind F; Department of Nuclear Medicine, Medical Center, University of Freiburg, Freiburg, Germany., Pizzuto DA; Direzione Scientifica GSTeP Radiopharmacy, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy., Soeterik TFW; Department of Radiation Oncology, University Medical Center Utrecht, Netherlands; Department of Urology, St Antonius Hospital Utrecht, Utrecht, Netherlands., Kömek H; Department of Nuclear Medicine, University of Health Sciences, Gazi Yasargil Training and Research Hospital, Diyarbakır, Turkey., Emmett L; Department of Theranostics and Nuclear medicine, St Vincent's Hospital, Sydney, Australia., Vondrak A; IZOTOPCENTRUM, Nuclear Medicine Department, Nitra, Slovakia., Pinter T; IZOTOPCENTRUM, Nuclear Medicine Department, Nitra, Slovakia., Lanfranchi F; Department of Experimental Medicine (DIMES), University of Genova, Genova, Italy., Bauckneht M; Nuclear Medicine, Department of Health Sciences (DISSAL), University of Genova, Genova, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy., Unterrainer LM; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany., Holzgreve A; Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany., Bjartell A; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden., Trägårdh E; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Clinical Physiology and Nuclear Medicine, Skåne University Hospital, Malmö, Sweden; Wallenberg Centre of Molecular Medicine, Lund University, Lund, Sweden., Rasul S; Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University Vienna, Vienna, Austria., Miszczyk M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Collegium Medicum-Faculty of Medicine, WSB University, Dąbrowa Górnicza, Poland., Bögemann M; Department of Urology, University Hospital Münster and West German Cancer Center, Münster, Germany., Rodriguez SantAnna Jauregui N; Department of Nuclear Medicine, University Hospital Münster and West German Cancer Center, Münster, Germany., Schäfers M; Department of Nuclear Medicine, University Hospital Münster and West German Cancer Center, Münster, Germany., Rahbar K; Department of Nuclear Medicine, University Hospital Münster and West German Cancer Center, Münster, Germany., Hadaschik BA; Department of Urology, DKTK and NCT University Hospital Essen, Essen, Germany., Fendler WP; Department of Nuclear Medicine, DKTK and NCT University Hospital Essen, Essen, Germany. Electronic address: wolfgang.fendler@uk-essen.de.
Corporate Authors: PROMISE Registry Group
Source: The Lancet. Oncology [Lancet Oncol] 2026 Apr; Vol. 27 (4), pp. 480-490. Date of Electronic Publication: 2026 Mar 09.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(26)00016-1